These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30288116)

  • 41. Risk factors, epidemiology and prognosis of cholangiocarcinoma in Finland.
    Barner-Rasmussen N; Pukkala E; Hadkhale K; Färkkilä M
    United European Gastroenterol J; 2021 Dec; 9(10):1128-1135. PubMed ID: 34533900
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study.
    Welzel TM; Mellemkjaer L; Gloria G; Sakoda LC; Hsing AW; El Ghormli L; Olsen JH; McGlynn KA
    Int J Cancer; 2007 Feb; 120(3):638-41. PubMed ID: 17109384
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is exposure to tobacco associated with extrahepatic cholangiocarcinoma epidemics? A retrospective proportional mortality study in China.
    Hou L; Jiang J; Liu B; Han W; Wu Y; Zou X; Xue F; Chen Y; Zhang B; Pang H; Wang Y; Wang Z; Hu Y; Li J
    BMC Cancer; 2019 Apr; 19(1):348. PubMed ID: 30975121
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of Statins on the Risk of Extrahepatic Cholangiocarcinoma.
    Lavu S; Therneau TM; Harmsen WS; Mara KC; Wongjarupong N; Hassan M; Ali HA; Antwi S; Giama NH; Miyabe K; Roberts LR
    Hepatology; 2020 Oct; 72(4):1298-1309. PubMed ID: 32119126
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk factors for extrahepatic cholangiocarcinoma: a case-control study in China.
    Zhou Z; Nie SD; Jiang B; Wang J; Lv P
    Eur J Cancer Prev; 2019 Jul; 28(4):254-257. PubMed ID: 30299315
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China.
    Zhou YM; Yin ZF; Yang JM; Li B; Shao WY; Xu F; Wang YL; Li DQ
    World J Gastroenterol; 2008 Jan; 14(4):632-5. PubMed ID: 18203300
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis.
    Zhou H; Wang H; Zhou D; Wang H; Wang Q; Zou S; Tu Q; Wu M; Hu H
    Eur J Cancer; 2010 Apr; 46(6):1056-61. PubMed ID: 20202823
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatitis C accelerates extrahepatic cholangiocarcinoma risk: a joint study of hospital-based cases and nationwide population-based cohorts in a viral hepatitis-endemic area.
    Huang SW; Cheng JS; Chen WT; Wu TS; Ku HP; Yeh CN; Chien RN; Chang ML
    Am J Cancer Res; 2023; 13(7):3080-3090. PubMed ID: 37559993
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association Between Cholangiocarcinoma and Proton Pump Inhibitors Use: A Nested Case-Control Study.
    Peng YC; Lin CL; Hsu WY; Chow WK; Lee SW; Yeh HZ; Chen CC; Kao CH
    Front Pharmacol; 2018; 9():718. PubMed ID: 30018559
    [No Abstract]   [Full Text] [Related]  

  • 50. Insulin therapy and biliary tract cancer: insights from real-world data.
    Qi X; He P; Yao H; Sun H; Qi J; Cao M; Cui B; Ning G
    Endocr Connect; 2022 Mar; 11(3):. PubMed ID: 35148280
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk factors for cholangiocarcinoma in the lower part of Northeast Thailand: a hospital-based case-control study.
    Manwong M; Songserm N; Promthet S; Matsuo K
    Asian Pac J Cancer Prev; 2013; 14(10):5953-6. PubMed ID: 24289607
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Body Mass Index, Diabetes and Intrahepatic Cholangiocarcinoma Risk: The Liver Cancer Pooling Project and Meta-analysis.
    Petrick JL; Thistle JE; Zeleniuch-Jacquotte A; Zhang X; Wactawski-Wende J; Van Dyke AL; Stampfer MJ; Sinha R; Sesso HD; Schairer C; Rosenberg L; Rohan TE; Robien K; Purdue MP; Poynter JN; Palmer JR; Newton CC; Linet MS; Liao LM; Lee IM; Koshiol J; Kitahara CM; Hofmann JN; Graubard BI; Giovannucci E; Gaziano MJ; Gapstur SM; Freedman ND; Chong DQ; Chan AT; Buring JE; Freeman LBE; Campbell PT; McGlynn KA
    Am J Gastroenterol; 2018 Oct; 113(10):1494-1505. PubMed ID: 30177781
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Liver transplantation for intrahepatic cholangiocarcinoma.
    Lee DD; Croome KP; Musto KR; Melendez J; Tranesh G; Nakhleh R; Taner CB; Nguyen JH; Patel T; Harnois DM
    Liver Transpl; 2018 May; 24(5):634-644. PubMed ID: 29514406
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association between periductal fibrosis and bile duct dilatation among a population at high risk of cholangiocarcinoma: a cross-sectional study of cholangiocarcinoma screening in Northeast Thailand.
    Chamadol N; Khuntikeo N; Thinkhamrop B; Thinkhamrop K; Suwannatrai AT; Kelly M; Promthet S
    BMJ Open; 2019 Mar; 9(3):e023217. PubMed ID: 30898798
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diabetes mellitus and increased risk of extrahepatic cholangiocarcinoma: a meta-analysis.
    Zhang LF; Zhao HX
    Hepatogastroenterology; 2013 Jun; 60(124):684-7. PubMed ID: 23321031
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Statins are associated with a reduced risk of cholangiocarcinoma: a population-based case-control study.
    Peng YC; Lin CL; Hsu WY; Chang CS; Yeh HZ; Tung CF; Wu YL; Sung FC; Kao CH
    Br J Clin Pharmacol; 2015 Oct; 80(4):755-61. PubMed ID: 25808421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combined hepatocellular-cholangiocarcinoma: can we use contrast-enhanced ultrasound Liver Imaging Reporting and Data System (LI-RADS) to predict the patient's survival?
    Yang J; Huang JY; Chen X; Ling WW; Luo Y; Shi YJ; Liu JB; Lu Q; Lyshchik A
    Eur Radiol; 2021 Aug; 31(8):6397-6405. PubMed ID: 33492470
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Survival of Patients with Cholangiocarcinoma Receiving Surgical Treatment in an O. viverrini Endemic Area in Thailand: A Retrospective Cohort Study.
    Chansitthichok S; Chamnan P; Sarkhampee P; Lertsawatvicha N; Voravisutthikul P; Wattanarath P
    Asian Pac J Cancer Prev; 2020 Apr; 21(4):903-909. PubMed ID: 32334449
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mixed hepatocellular and cholangiocarcinoma: a rare tumor with a mix of parent phenotypic characteristics.
    Bergquist JR; Groeschl RT; Ivanics T; Shubert CR; Habermann EB; Kendrick ML; Farnell MB; Nagorney DM; Truty MJ; Smoot RL
    HPB (Oxford); 2016 Nov; 18(11):886-892. PubMed ID: 27546172
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatitis B and C virus infection is a risk factor for the development of cholangiocarcinoma.
    Matsumoto K; Onoyama T; Kawata S; Takeda Y; Harada K; Ikebuchi Y; Ueki M; Miura N; Yashima K; Koda M; Sakamoto T; Endo M; Horie Y; Murawaki Y
    Intern Med; 2014; 53(7):651-4. PubMed ID: 24694471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.